Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.675 USD | -0.19% | -9.25% | +167.00% |
18/04 | JonesTrading Starts Rezolute With Buy Rating, $10 Price Target | MT |
06/03 | Rezolute, Inc. Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+167.00% | 108M | |
+6.26% | 111B | |
+11.74% | 106B | |
-12.44% | 22.24B | |
+0.09% | 21.25B | |
-4.78% | 18.97B | |
-35.21% | 18.52B | |
-11.43% | 16.81B | |
+38.14% | 12.54B | |
-25.11% | 8.09B |
- Stock Market
- Equities
- RZLT Stock
- News Rezolute, Inc.
- Jefferies Initiates Rezolute at Buy With $11 Price Target